Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA.
about
Targeted DNA mutagenesis for the cure of chronic viral infectionsHematopoietic Stem and Immune Cells in Chronic HIV InfectionRecent developments in human immunodeficiency virus-1 latency researchT memory stem cells and HIV: a long-term relationshipEffects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.Is the central nervous system a reservoir of HIV-1?Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAARTAutograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.HIV-1 Is Restricted prior to Integration of Viral DNA in Primary Cord-Derived Human CD34+ Cells.Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes.An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cellsCD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppression.HIV-1 transcription and latency: an update.Animal models to achieve an HIV cureTissue reservoirs of HIVHIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice.HIV-1 persistence in CD4+ T cells with stem cell-like properties.HIV-1 Reservoirs During Suppressive Therapy.Developing strategies for HIV-1 eradicationIs specific HIV eradication from the brain possible or needed?Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials.Eradication of HIV and Cure of AIDS, Now and How?HIV/AIDS: modified stem cells in the spotlight.HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Potential implication of residual viremia in patients on effective antiretroviral therapy.Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.Mechanisms of HIV persistence in HIV reservoirs.HIV and Stem Cell Transplantation.Underlying mechanisms of HIV-1 latency.Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.Toward a Cure: Does Host Immunity Play a Role?Quiescence promotes latent HIV infection and resistance to reactivation from latency with histone deacetylase inhibitors.The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time
P2860
Q24620150-6CC26DBF-6435-49A6-86B5-802B419A9D25Q26795450-BE4CBBB5-1D02-437A-95DB-C5092B9E395AQ27013114-46CF8F84-3F3B-47E9-A5D7-281E9ED3F162Q27023930-286D0681-6BA5-46FF-9A0F-C2779C4E760FQ33411216-28B5BDB4-A8B0-4174-9205-793EFB06E4B0Q34434339-1824CDCF-4AE1-4429-81A3-DAE1B74A0F0EQ34647798-24E007CE-1515-462A-9C3D-7CA4F6D922C2Q34869326-60C91BEB-CB0E-4ED0-96DB-0A564CFA7EC5Q35252186-F95ADB27-0464-4E2C-850A-09E6D30ACC3EQ35861171-2DE58644-F50A-42BB-B21A-BBF8FDC0F4CFQ35965172-50932CAB-A407-45BC-B0AD-EE41943871B1Q36155046-3A2A7B8D-56CB-4297-ABEC-8A1B78F6AABFQ36281833-943DA2A0-9FD1-417F-8B03-A0EBF59296BCQ36404157-C4764938-5C9B-40D1-9451-5DD3FDF300DCQ36559821-6523CA5F-0358-4EC1-8886-785ADC96230EQ36846285-6F926CBF-3D42-4A3B-B3C1-83DA1295E670Q36976156-A745BB74-9636-4FDF-B9B2-9921D71E1499Q37041160-C8592F66-A99C-4D42-BEDC-D01F0512D600Q37055454-2EEB07DD-7CCD-4BBD-980B-AC3747B6B222Q37202288-8DE64F4B-1F47-49C5-967C-088A342810ECQ37646541-83419398-59B7-4ACE-A624-E4ECE3E9C282Q37656766-31CB96CC-7EA5-4FEA-9E1E-9FCC78E29993Q38032363-0C5705EA-B861-4077-997B-1A790415096CQ38071699-E7581319-FC63-4B69-BB36-0B5EE7C127AEQ38078562-5EAD0BCB-9586-4FEC-957C-EB68192746BCQ38096822-B792483B-42D0-4133-BED9-3BB65EBFB2E2Q38154888-04F36F86-3006-4FF9-A89B-6947B1100AD0Q38186557-23EDB48C-D0AA-4F18-983F-B80B7B94CE86Q38204866-9FB179B8-26AC-4BF2-9D2F-9E3106769B2CQ38246141-9F657E5F-E931-4DA2-949F-CFDA2D39B6A5Q38271917-B4368D49-AE39-448B-805E-61CC04978598Q38619193-5A9D8D8A-372B-40C4-9AD7-B84B710D6530Q38667923-DE741681-5BE8-4D41-8CBF-4667B9FEF93AQ39106572-ED7392F5-1F43-401D-9244-E48ED2C09CCEQ39145369-901106CB-DD00-47EE-AFD2-AE5A2C75D7D4Q39160623-EF0BA56E-5B28-4E22-98A3-A482997A1ACDQ39315697-D7B7758E-6AA8-48E0-ABD3-690C01433102Q40204515-1C8C0C3E-E9E2-4C0D-8DE7-25B3D157F9B7Q41918740-50E5665D-2630-4447-98B9-9FC1A2115F25Q41954397-9126A0E9-74F5-457C-9CE1-82040D22410F
P2860
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@ast
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@en
type
label
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@ast
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@en
prefLabel
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@ast
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@en
P2093
P2860
P356
P1476
Hematopoietic precursor cells ...... apy did not contain HIV-1 DNA.
@en
P2093
Bradley Lewis
Elizabeth Sinclair
Jeff Custer
Lauren Poole
Lina Josefsson
Lorrie Epling
Maudi Killian
Peter Bacchetti
Sarah Palmer
P2860
P356
10.1093/INFDIS/JIS301
P407
P577
2012-04-25T00:00:00Z